By Jacqueline Howard, CNN A new treatment for amyotrophic lateral sclerosis, or ALS, has been approved by the US Food and Drug Administration. The FDA announced approval of Relyvrio, developed by Amylyx Pharmaceuticals, on Thursday.
A drug from Amylyx Pharmaceuticals to treat ALS, or Lou Gehrig’s disease, won U.S. approval on Thursday from the Food and Drug Administration based on the results of a small, mid-stage study.
The Food and Drug Administration (FDA) approved a new drug to treat ALS Thursday despite concerns from its own scientists that the drug isn't effective.
FRIDAY, Sept. 30, 2022 (HealthDay News) – The U.S. Food and Drug Administration on Thursday gave its approval to a new drug for ALS (amyotrophic lateral sclerosis), also known as
A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.
By Jacqueline Howard, CNN A new treatment for amyotrophic lateral sclerosis, or ALS, has been approved by the US Food and Drug Administration. The FDA announced approval of Relyvrio, developed by Amylyx Pharmaceuticals, on Thursday.